Thus, we clarify that overexpression of Bcl-3 affects T-cell function, whereas Bcl-3 deficiency acts by enhancing epithelial cell survival, targeting the activity of Bcl-3 in inflammatory bowel disease may be a valid tactic to inhibit intestinal inflammation. The gene discussed is BCL3; the disease is inflammatory bowel disease.